Clinical Trial Update: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating capecitabine and streptozocin with or without cisplatin in unresectable or metastatic neuroendocrine tumors has completed. The snippet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Carcinoid Tumor
• Islet Cell Tumor

Drugs mentioned

• Platinol (cisplatin)
• Xeloda (capecitabine)
• Zanosar (streptozocin)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 | Status: COMPLETED